|
|
 |
|
Viewing report
|
|
|
Thought Leader Insight & Analysis Report - Osteoporosis Q4 2011
Medpredict, Oct 2011, Pages: 134
Osteoporosis Thought Leader Panel #53 summarizes an Advisory Board that BOLT International / MedPredict conducted with our Thought Leaders after the ASBMR 2011. The Panel reviewed the highlights (lowlights) from the meeting, and touched on important pipeline advances for both antiresorptives (cathepsin K inhibitors, strontium, RANKL, oral calcitonin) and anabolics (anti-sclerostin, PTH variants). The Panel also weighed in on the FDA Advisory Committee Meeting on Bisphosphonates.
|
|
|
|
